IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

87 hedge funds and large institutions have $345M invested in Iovance Biotherapeutics in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 16 closing their positions.

Holders
87
Holders Change
-6
Holders Change %
-6.45%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
11
Increased
38
Reduced
20
Closed
16
Calls
$2.05M
Puts
$3.02M
Net Calls
-$969K
Net Calls Change
+$5.91M

Top Buyers

1
Franklin Resources
1
Franklin Resources
California
$36.2M
2
ACP
2
Acuta Capital Partners
California
$26.5M
3
BFA
3
BlackRock Fund Advisors
California
$18.5M
4
ACA
4
Avoro Capital Advisors
New York
$31.4M
5
GTC
5
Ghost Tree Capital
New York
$6.78M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$31.1M
2
CAM
2
Cormorant Asset Management
Massachusetts
$0
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$0
4
QF
4
QVT Financial
New York
$10.3M
5
OAM
5
Oxford Asset Management
United Kingdom
$696K
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
101
Acrospire Investment Management
Illinois
– – -1,584 Closed
Federated Hermes
102
Federated Hermes
Pennsylvania
– – -1,221 Closed
WTB
103
Washington Trust Bank
Washington
$0 57 – –
1 2 3 4
5